nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells
|
Kanamori, Y |
|
1998 |
34 |
11 |
p. 1802-1806 5 p. |
artikel |
2 |
A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma
|
Ford, J |
|
1998 |
34 |
11 |
p. 1807-1811 5 p. |
artikel |
3 |
A 15-year overview of management and prognosis in primary fallopian tube carcinoma
|
Rosen, A.C. |
|
1998 |
34 |
11 |
p. 1725-1729 5 p. |
artikel |
4 |
Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients
|
Frasci, G |
|
1998 |
34 |
11 |
p. 1710-1714 5 p. |
artikel |
5 |
Correspondence
|
|
|
1998 |
34 |
11 |
p. 1812-1813 2 p. |
artikel |
6 |
Correspondence
|
|
|
1998 |
34 |
11 |
p. 1812- 1 p. |
artikel |
7 |
Correspondence
|
|
|
1998 |
34 |
11 |
p. 1815- 1 p. |
artikel |
8 |
Correspondence
|
|
|
1998 |
34 |
11 |
p. 1816-1817 2 p. |
artikel |
9 |
Correspondence
|
|
|
1998 |
34 |
11 |
p. 1813-1814 2 p. |
artikel |
10 |
Detection of melanomas by digital imaging of spectrally resolved ultraviolet light-induced autofluorescence of human skin
|
Chwirot, B.W |
|
1998 |
34 |
11 |
p. 1730-1734 5 p. |
artikel |
11 |
Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer
|
Colleoni, M |
|
1998 |
34 |
11 |
p. 1693-1700 8 p. |
artikel |
12 |
Editorial
|
|
|
1998 |
34 |
11 |
p. 1659-1663 5 p. |
artikel |
13 |
Editorial
|
|
|
1998 |
34 |
11 |
p. 1649-1651 3 p. |
artikel |
14 |
Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines
|
Damia, G |
|
1998 |
34 |
11 |
p. 1783-1788 6 p. |
artikel |
15 |
Expression of Tenascin-C in intraductal carcinoma of human breast: relationship to invasion
|
Jahkola, T |
|
1998 |
34 |
11 |
p. 1687-1692 6 p. |
artikel |
16 |
Fatigue in patients with cancer
|
Stone, P. |
|
1998 |
34 |
11 |
p. 1670-1676 7 p. |
artikel |
17 |
Incidentally found adrenocortical carcinoma. A study of 21 patients
|
Kasperlik-Załuska, A.A |
|
1998 |
34 |
11 |
p. 1721-1724 4 p. |
artikel |
18 |
Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance
|
Barnes, D.M |
|
1998 |
34 |
11 |
p. 1677-1682 6 p. |
artikel |
19 |
Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan
|
Lin, Y.-W |
|
1998 |
34 |
11 |
p. 1789-1795 7 p. |
artikel |
20 |
Is there a standard adjuvant treatment for colon cancer?
|
Slevin, M.L |
|
1998 |
34 |
11 |
p. 1652-1655 4 p. |
artikel |
21 |
Is there a standard adjuvant treatment for colon cancer?
|
Rougier, P |
|
1998 |
34 |
11 |
p. 1655-1659 5 p. |
artikel |
22 |
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients
|
Sakata, Y |
|
1998 |
34 |
11 |
p. 1715-1720 6 p. |
artikel |
23 |
Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer
|
Niederacher, D |
|
1998 |
34 |
11 |
p. 1770-1776 7 p. |
artikel |
24 |
Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial
|
De Conno, F |
|
1998 |
34 |
11 |
p. 1705-1709 5 p. |
artikel |
25 |
Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein
|
Garcı́a de Veas, R. |
|
1998 |
34 |
11 |
p. 1736-1740 5 p. |
artikel |
26 |
Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers
|
Osin, P |
|
1998 |
34 |
11 |
p. 1683-1686 4 p. |
artikel |
27 |
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers
|
Collecchi, P |
|
1998 |
34 |
11 |
p. 1701-1704 4 p. |
artikel |
28 |
Selective induction of apoptosis in multidrug resistant HL60R cells by the thiazolobenzoimidazole derivative 1-(2,6-difluorophenyl)-1H,3H-thiazolo [3,4-a] benzimidazole (TBZ)
|
Grimaudo, S |
|
1998 |
34 |
11 |
p. 1756-1763 8 p. |
artikel |
29 |
Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model
|
Uchida, N |
|
1998 |
34 |
11 |
p. 1796-1801 6 p. |
artikel |
30 |
Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier
|
Nagamitsu, A. |
|
1998 |
34 |
11 |
p. 1764-1769 6 p. |
artikel |
31 |
The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O6-alkylguanine-DNA-alkyltransferase of human tumour xenografts
|
D’Incalci, M |
|
1998 |
34 |
11 |
p. 1749-1755 7 p. |
artikel |
32 |
The fourth EORTC DCIS consensus meeting (Château Marquette, Heemskerk, The Netherlands, 23–24 January 1998)—Conference report
|
Recht, A |
|
1998 |
34 |
11 |
p. 1664-1669 6 p. |
artikel |
33 |
Transcription of the prorenin gene in normal and diseased breast
|
Tahmasebi, M |
|
1998 |
34 |
11 |
p. 1777-1782 6 p. |
artikel |
34 |
Vincristine- and cisplatin-induced apoptosis in human retinoblastoma. Potentiation by sodium butyrate
|
Conway, R.M |
|
1998 |
34 |
11 |
p. 1741-1748 8 p. |
artikel |